tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Oric Pharmaceuticals’ ORIC-944: A Promising PRC2 Inhibitor with Strategic Partnerships and Market Potential
PremiumRatingsOric Pharmaceuticals’ ORIC-944: A Promising PRC2 Inhibitor with Strategic Partnerships and Market Potential
2M ago
ORIC Pharmaceuticals Reports Q2 2025 Financial Results
Premium
Company Announcements
ORIC Pharmaceuticals Reports Q2 2025 Financial Results
2M ago
Oric Pharmaceuticals appoints Kevin Brodbeck CTO
Premium
The Fly
Oric Pharmaceuticals appoints Kevin Brodbeck CTO
2M ago
Oric Pharmaceuticals reports Q2 EPS (47c), consensus (44c)
PremiumThe FlyOric Pharmaceuticals reports Q2 EPS (47c), consensus (44c)
2M ago
Oric Pharmaceuticals initiated with a Buy at Ladenburg
Premium
The Fly
Oric Pharmaceuticals initiated with a Buy at Ladenburg
4M ago
Oric Pharmaceuticals Elects Directors at Annual Meeting
Premium
Company Announcements
Oric Pharmaceuticals Elects Directors at Annual Meeting
4M ago
Oric Pharmaceuticals data ‘home run scenario,’ says JPMorgan
PremiumThe FlyOric Pharmaceuticals data ‘home run scenario,’ says JPMorgan
5M ago
Buy Rating for Oric Pharmaceuticals Driven by Promising ORIC-944 Study Results and Undervaluation
Premium
Ratings
Buy Rating for Oric Pharmaceuticals Driven by Promising ORIC-944 Study Results and Undervaluation
5M ago
Closing Bell Movers: Nvidia gains 4% on earnings, lifting other semis
Premium
The Fly
Closing Bell Movers: Nvidia gains 4% on earnings, lifting other semis
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100